Prostate cancer-related deaths have decreased over the last few years, in part due to the extensive use of screening strategies such as digital rectal examination and the measurement of serum levels of prostate-specific antigen (PSA) [21]. This evidence concerns the gene KLK3 and prostate carcinoma.